kabutan

TRANSGENIC GROUP INC.(2342) Summary

2342
TSE Growth
TRANSGENIC GROUP INC.
260
JPY
-12
(-4.41%)
Dec 12, 3:30 pm JST
1.66
USD
Dec 12, 1:30 am EST
Result
PTS
outside of trading hours
254
Dec 12, 11:58 pm JST
Summary Chart Historical News Financial Result
PER
108.3
PBR
0.90
Yield
ー%
Margin Trading Ratio
Stock Price
Dec 12, 2025
Opening Dec 12, 9:00 am
269 JPY 1.72 USD
Previous Close Dec 11
272 JPY 1.74 USD
High Dec 12, 9:07 am
278 JPY 1.78 USD
Low Dec 12, 1:24 pm
253 JPY 1.62 USD
Volume
795,800
Trading Value
0.21B JPY 1.35M USD
VWAP
263.62 JPY 1.69 USD
Minimum Trading Value
26,000 JPY 166 USD
Market Cap
4.42B JPY 0.03B USD
Number of Trades
1,073
Liquidity & Number of Trades
As of Dec 12, 2025
Liquidity
Slightly High
1-Year Average
476
1-Year High Dec 4, 2025
20,104
Margin Trading
Date Short Interest Long Margin Positions Ratio
Dec 5, 2025 9,200 1,401,500 152.34
Nov 28, 2025 114,600 1,605,200 14.01
Nov 21, 2025 400 1,188,400 2971.00
Nov 14, 2025 0 995,200
Nov 7, 2025 0 959,400
Company Profile
TRANSGENIC GROUP INC. is a biotech venture supporting drug discovery research. The company specializes in genetic analysis using mice and is expanding through succession-based M&A.
Sector
Services
TRANSGENIC GROUP INC. operates two main business segments: drug discovery support and investment/consulting. In the drug discovery support segment, the company offers services such as genetically modified mouse production, antibody production, glycan analysis and synthesis, preclinical trials, and clinical trial outsourcing. The investment and consulting segment focuses on promoting new businesses through M&A and supporting business succession and revitalization. This segment includes various activities such as the sale of electrical products, import and sale of Western tableware, development and sale of information and communication equipment, import and sale of auxiliary materials for multi-layered glass and glass processing equipment, and import and sale of printer toners.